{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:12:52Z","timestamp":1779923572880,"version":"3.53.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1093\/ndt\/gfh871","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T02:02:56Z","timestamp":1115776976000},"page":"1623-1629","source":"Crossref","is-referenced-by-count":20,"title":["Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites"],"prefix":"10.1093","volume":"20","author":[{"given":"Georgios","family":"Kalambokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Economou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad Al","family":"Bokharhii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afroditi","family":"Katsaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epameinondas V.","family":"Tsianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,5,10]]},"reference":[{"key":"key\n\t\t\t\t20171011061547_BIB1","doi-asserted-by":"crossref","unstructured":"Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol2003; 38: S69\u2013S89","DOI":"10.1016\/S0168-8278(03)00007-2"},{"key":"key\n\t\t\t\t20171011061547_BIB2","doi-asserted-by":"crossref","unstructured":"Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology1992; 15: 323\u2013328","DOI":"10.1002\/hep.1840150224"},{"key":"key\n\t\t\t\t20171011061547_BIB3","doi-asserted-by":"crossref","unstructured":"Garcia-Pagan JC, Salmeron JM, Feu F et al. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology1994; 19: 1095\u20131099","DOI":"10.1002\/hep.1840190506"},{"key":"key\n\t\t\t\t20171011061547_BIB4","doi-asserted-by":"crossref","unstructured":"Bataller R, Gines P, Arroyo V. Practical recommendations for the treatment of ascites and its complications. Drugs1997; 54: 571\u2013578","DOI":"10.2165\/00003495-199754040-00004"},{"key":"key\n\t\t\t\t20171011061547_BIB5","unstructured":"Bernardi M, Trevisani R, Capelli M et al. Study of renal function, renin-aldosterone axis and plasma electrolytes during diuretic treatment of patients with cirrhosis of the liver and ascites. Ital J Gastroenterol1982; 14: 199\u2013204"},{"key":"key\n\t\t\t\t20171011061547_BIB6","doi-asserted-by":"crossref","unstructured":"Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol1986; 250: R960\u2013R972","DOI":"10.1152\/ajpregu.1986.250.6.R960"},{"key":"key\n\t\t\t\t20171011061547_BIB7","doi-asserted-by":"crossref","unstructured":"Sieber CC, Lee FY, Groszmann RJ. Long-term octreotide treatment prevents vascular hyporeactivity in portal hypertensive rats. Hepatology1996; 23: 1218\u20131223","DOI":"10.1002\/hep.510230541"},{"key":"key\n\t\t\t\t20171011061547_BIB8","doi-asserted-by":"crossref","unstructured":"Piccueta MP, Casamitjana R, Bosch J, Rodes J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Phsiol1990; 258: G191\u2013G195","DOI":"10.1152\/ajpgi.1990.258.2.G191"},{"key":"key\n\t\t\t\t20171011061547_BIB9","doi-asserted-by":"crossref","unstructured":"Kurokawa K, Aponte G, Fujibayashi S, Yamada T. Somatostatin-like immunoreactivity in the glomerulus of rat kidney. Kidney Int1983; 24: 754\u2013757","DOI":"10.1038\/ki.1983.223"},{"key":"key\n\t\t\t\t20171011061547_BIB10","doi-asserted-by":"crossref","unstructured":"Izumi Y, Honda M, Hartano M. Effect of somatostatin on plasma renin activity. Endocrinol Jpn1979; 26: 389\u2013394","DOI":"10.1507\/endocrj1954.26.389"},{"key":"key\n\t\t\t\t20171011061547_BIB11","doi-asserted-by":"crossref","unstructured":"Aguilera G, Parker DS, Gatt KJ. Characterization of somatostatin receptors in rat adrenal glomerulosa zone. Endocrinology1982; 111: 1376\u20131382","DOI":"10.1210\/endo-111-4-1376"},{"key":"key\n\t\t\t\t20171011061547_BIB12","doi-asserted-by":"crossref","unstructured":"Aguilera G, Parker DS, Gatt KJ. Somatostatin modulates effects of Angiotensin II in adrenal glomerulosa zone. Nature1982; 292: 262\u2013263","DOI":"10.1038\/292262a0"},{"key":"key\n\t\t\t\t20171011061547_BIB13","doi-asserted-by":"crossref","unstructured":"Rosenthal J, Escobar-Jimenez F, Raptis S, Pfeiffer EF. Inhibition of furosemide induced hyperreninaemia by growth hormone release inhibiting hormone in man. Lancet1976; 1: 772\u2013774","DOI":"10.1016\/S0140-6736(76)91611-1"},{"key":"key\n\t\t\t\t20171011061547_BIB14","doi-asserted-by":"crossref","unstructured":"Rosenthal J, Escobar-Jimenez F, Raptis S. Prevention of somatostatin rise in blood pressure and plasma renin activity mediated by beta-receptor stimulation. Clin Endocrinol1977; 6: 455\u2013462","DOI":"10.1111\/j.1365-2265.1977.tb03329.x"},{"key":"key\n\t\t\t\t20171011061547_BIB15","doi-asserted-by":"crossref","unstructured":"Arlart I, Rosenthal J, Pal S, Raptis S. Einfluss von Somatostatin auf Renin, Aldosteron und Blutdruck bei unilateraler renovaskularer Hypertonie. Verhandl Deutsh Gesell Inn Med1978; 84: 824\u2013827","DOI":"10.1007\/978-3-642-85453-8_180"},{"key":"key\n\t\t\t\t20171011061547_BIB16","doi-asserted-by":"crossref","unstructured":"Sieber C, Gnadinger M, del Pozo E, Shaw S, Weidmann P. Effect of a new Somatostatin analogue SMS 201-995 (sandostatin) on the renin-aldosterone axis. Clin Endocrinol1988; 28: 25\u201332","DOI":"10.1111\/j.1365-2265.1988.tb01199.x"},{"key":"key\n\t\t\t\t20171011061547_BIB17","doi-asserted-by":"crossref","unstructured":"Jones CR, Millar JA, Lawrie C, Summer DJ, Reid JL. Specific inhibition of aldosterone responses to endogenous and exogenous angiotensin II by somatostatin. Clin Endocrinol1984; 21: 279\u2013284","DOI":"10.1111\/j.1365-2265.1984.tb03470.x"},{"key":"key\n\t\t\t\t20171011061547_BIB18","doi-asserted-by":"crossref","unstructured":"Albillos A, Colombato LA, Lee FY, Groszmann J. Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats. Gastroenterology1993; 104: 575\u2013579","DOI":"10.1016\/0016-5085(93)90429-G"},{"key":"key\n\t\t\t\t20171011061547_BIB19","doi-asserted-by":"crossref","unstructured":"Sabat M, Guarner C, Soriano G et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci1998; 43: 2184\u20132189","DOI":"10.1023\/A:1026698001921"},{"key":"key\n\t\t\t\t20171011061547_BIB20","doi-asserted-by":"crossref","unstructured":"Kalambokis G, Economou M, Fotopoulos A et al. The effects of chronic treatment with octreotide vs octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol2005, 100: 879\u2013885","DOI":"10.1111\/j.1572-0241.2005.40899.x"},{"key":"key\n\t\t\t\t20171011061547_BIB21","doi-asserted-by":"crossref","unstructured":"Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology1996; 23: 164\u2013176","DOI":"10.1002\/hep.510230122"},{"key":"key\n\t\t\t\t20171011061547_BIB22","doi-asserted-by":"crossref","unstructured":"Brater DC. Diuretic therapy. N Engl J Med1998; 339: 387\u2013395","DOI":"10.1056\/NEJM199808063390607"},{"key":"key\n\t\t\t\t20171011061547_BIB23","doi-asserted-by":"crossref","unstructured":"Blaufox MD. Measurement of renal function with radioactive materials. In: Blaufox MD, ed. Evaluation of renal function and disease with radionuclides. The upper urinary tract. Basel: Karger, 1989: 12\u201327","DOI":"10.1159\/000417122"},{"key":"key\n\t\t\t\t20171011061547_BIB24","doi-asserted-by":"crossref","unstructured":"Van de Casteele M, Van Roey G, Nevens F et al. Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in portal vein ligated rats. Hepatology1996; 24: 1492\u20131496","DOI":"10.1002\/hep.510240632"},{"key":"key\n\t\t\t\t20171011061547_BIB25","doi-asserted-by":"crossref","unstructured":"Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis2003; 41: 269\u2013278","DOI":"10.1053\/ajkd.2003.50035"},{"key":"key\n\t\t\t\t20171011061547_BIB26","doi-asserted-by":"crossref","unstructured":"Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol1977; 233: F366\u2013F372","DOI":"10.1152\/ajprenal.1977.233.5.F366"},{"key":"key\n\t\t\t\t20171011061547_BIB27","doi-asserted-by":"crossref","unstructured":"Berthold H, del Rozo E. Antidiuretic effect of Sandostatin (SMS 201\u2013995) in healthy volunteers. Acta Endocrinol (Copenh)1989; 120: 708\u2013714","DOI":"10.1530\/acta.0.1200708"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/20\/8\/1623\/5419317\/gfh871.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T08:54:59Z","timestamp":1586249699000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/20\/8\/1623\/1922080\/Renal-effects-of-treatment-with-diuretics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,10]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2005,5,10]]},"published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfh871","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,8]]},"published":{"date-parts":[[2005,5,10]]}}}